PMID- 29850454
OWN - NLM
STAT- MEDLINE
DCOM- 20190211
LR  - 20190215
IS  - 2291-2797 (Electronic)
IS  - 2291-2789 (Print)
IS  - 2291-2789 (Linking)
VI  - 2018
DP  - 2018
TI  - Long-Term Management of Recurrent Cholecystitis after Initial Conservative 
      Treatment: Endoscopic Transpapillary Gallbladder Stenting.
PG  - 3983707
LID - 10.1155/2018/3983707 [doi]
LID - 3983707
AB  - BACKGROUND: Endoscopic transpapillary gallbladder stenting (ETGBS) is an 
      effective procedure for treating high-risk patients with acute cholecystitis and 
      severe comorbidities. However, the efficacy of ETGBS for recurrent cholecystitis 
      (RC) remains unclear. This study aimed to explore its efficacy in patients with 
      RC for whom cholecystectomy is contraindicated because of its high surgical risk. 
      METHODS: Data on 19 high-risk patients who had undergone ETGBS for RC after 
      initial conservative therapy in our institution between June 2006 and May 2012 
      were retrospectively examined. The primary outcome was the clinical success rate, 
      which was defined as no recurrences of acute cholecystitis after ETGBS until 
      death or the end of the follow-up period. Secondary outcomes were technical 
      success rate and adverse events (AEs). RESULTS: The clinical success rate of 
      ETGBS was 100%, the technical success rate 94.7%, and AE rate 5%: one patient 
      developed procedure-related mild acute pancreatitis. The clinical courses of all 
      patients were as follows: four died of nonbiliary disease, and the remaining 15 
      were subsequently treated conservatively. The median duration of follow-up was 
      14.95 months (range 3-42 months). CONCLUSIONS: ETGBS is an effective alternative 
      for managing RC in high-risk patients with severe comorbidities.
FAU - Kamada, Hideki
AU  - Kamada H
AUID- ORCID: 0000-0002-0715-645X
AD  - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Kobara, Hideki
AU  - Kobara H
AD  - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Uchida, Naohito
AU  - Uchida N
AD  - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Kato, Kiyohito
AU  - Kato K
AD  - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Fujimori, Takayuki
AU  - Fujimori T
AD  - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Kobayashi, Kiyoyuki
AU  - Kobayashi K
AD  - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Yamashita, Takuma
AU  - Yamashita T
AD  - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Ono, Masahiro
AU  - Ono M
AD  - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Aritomo, Yuichi
AU  - Aritomo Y
AD  - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Tsutsui, Kunihiko
AU  - Tsutsui K
AD  - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Okano, Keiichi
AU  - Okano K
AD  - Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Suzuki, Yasuyuki
AU  - Suzuki Y
AD  - Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
FAU - Masaki, Tsutomu
AU  - Masaki T
AD  - Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa 
      University, Kagawa, Japan.
LA  - eng
PT  - Journal Article
DEP - 20180412
PL  - Egypt
TA  - Can J Gastroenterol Hepatol
JT  - Canadian journal of gastroenterology & hepatology
JID - 101623613
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Ampulla of Vater
MH  - Cholangiopancreatography, Endoscopic Retrograde/adverse effects/*methods
MH  - Cholecystitis, Acute/*therapy
MH  - Conservative Treatment
MH  - Female
MH  - Gallbladder
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Recurrence
MH  - Retreatment
MH  - Retrospective Studies
MH  - *Stents/adverse effects
MH  - Time Factors
PMC - PMC5925167
EDAT- 2018/06/01 06:00
MHDA- 2019/02/12 06:00
PMCR- 2018/04/12
CRDT- 2018/06/01 06:00
PHST- 2017/05/29 00:00 [received]
PHST- 2017/12/19 00:00 [revised]
PHST- 2018/01/14 00:00 [accepted]
PHST- 2018/06/01 06:00 [entrez]
PHST- 2018/06/01 06:00 [pubmed]
PHST- 2019/02/12 06:00 [medline]
PHST- 2018/04/12 00:00 [pmc-release]
AID - 10.1155/2018/3983707 [doi]
PST - epublish
SO  - Can J Gastroenterol Hepatol. 2018 Apr 12;2018:3983707. doi: 10.1155/2018/3983707. 
      eCollection 2018.